EDITORIALS

Back to the Future: Multiagent Chemotherapy in Ovarian Cancer Revisited

Stephen A. Cannistra

JCO Mar 1 1999: 741. [Full Text] [PDF]

Lymphocyte-Predominant Hodgkin's Disease: How Little Therapy Is Enough?

Jon C. Aster

JCO Mar 1 1999: 744. [Full Text] [PDF]

GYNECOLOGIC CANCER
	Phase I and Pharmacologic Study of the Combination of Paclitaxel, Cisplatin, and Topotecan Administered Intravenously Every 21 Days as First-Line Therapy in Patients With Advanced Ovarian Cancer
	Virginie M.M. Herben, Vinodh R. Nannan Panday, Dick J. Richel, Jan H.M. Schellens, Nine van der Vange, Hilde Rosing, Fred D. Beusenberg, Solange Hearn, Edward Doyle, Jos H. Beijnen, and Wim W. ten Bokkel Huinink
	JCO Mar 1 1999: 747. [Abstract] [Full Text] [PDF]
	Phase II Study of Cisplatin and Vinorelbine as First-Line Chemotherapy in Patients With Carcinoma of the Uterine Cervix
	Sandro Pignata, Giustino Silvestro, Ettore Ferrari, Luigi Selvaggi, Francesco Perrone, Antonio Maffeo, Pasquale Frezza, Giovanni Di Vagno, Gennaro Casella, Paolo Ricchi, Gennaro Cormio, Ciro Gallo, Francesco Iodice, Frank Romeo, Roberto Fiorentino, Giovanni Fortuna, and Sergio Tramontana
	JCO Mar 1 1999: 756. [Abstract] [Full Text] [PDF]
	Phase II Trial of Paclitaxel and Cisplatin in Metastatic and Recurrent Carcinoma of the Uterine Cervix
	Christos A. Papadimitriou, Kyrillos Sarris, Lia A. Moulopoulos, George Fountzilas, Athanassios Anagnostopoulos, Zannis Voulgaris, Dimitra Gika, Nikolaos Giannakoulis, Emmanuel Diakomanolis, and Meletios A. Dimopoulos
	JCO Mar 1 1999: 761. [Abstract] [Full Text] [PDF]
	Natural History of Stage IV Epithelial Ovarian Cancer
	H. Bonnefoi, R. P. A'Hern, C. Fisher, V. Macfarlane, D. Barton, P. Blake, J. H. Shepherd, and M. E. Gore
	JCO Mar 1 1999: 767. [Abstract] [Full Text] [PDF]

HEMATOLOGIC MALIGNANCIES
	Clinical Presentation, Course, and Prognostic Factors in Lymphocyte-Predominant Hodgkin's Disease and Lymphocyte-Rich Classical Hodgkin's Disease: Report From the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease
	Volker Diehl, Michael Sextro, Jeremy Franklin, Martin-Leo Hansmann, Nancy Harris, Elaine Jaffe, Sibr Poppema, Martin Harris, Kaarle Franssila, Jan van Krieken, Theresa Marafioti, Ioannis Anagnostopoulos, and Harald Stein
	JCO Mar 1 1999: 776. [Abstract] [Full Text] [PDF]
	Primary Mediastinal Large B-Cell Lymphoma: A Clinicopathologic Study of 43 Patients From the Nebraska Lymphoma Study Group
	Ashraf A. Abou-Elella, Dennis D. Weisenburger, Julie M. Vose, Jeffrey P. Kollath, James C. Lynch, Martin A. Bast, Philip J. Bierman, Timothy C. Greiner, Wing C. Chan, and James O. Armitage
	JCO Mar 1 1999: 784. [Abstract] [Full Text] [PDF]
	Rituximab Therapy in Hematologic Malignancy Patients With Circulating Blood Tumor Cells: Association With Increased Infusion-Related Side Effects and Rapid Blood Tumor Clearance
	John C. Byrd, Jamie K. Waselenko, Thomas J. Maneatis, Timothy Murphy, Frank T. Ward, Brian P. Monahan, Melissa A. Sipe, Sarah Donegan, and Christine A. White
	JCO Mar 1 1999: 791. [Abstract] [Full Text] [PDF]
	Pneumonia in Febrile Neutropenic Patients and in Bone Marrow and Blood Stem-Cell Transplant Recipients: Use of High-Resolution Computed Tomography
	Claus Peter Heussel, Hans-Ulrich Kauczor, Gudula E. Heussel, Berthold Fischer, Markus Begrich, Peter Mildenberger, and Manfred Thelen
	JCO Mar 1 1999: 796. [Abstract] [Full Text] [PDF]
	Long-Term Follow-Up of High-Risk Allogeneic Peripheral-Blood Stem-Cell Transplant Recipients: Graft-Versus-Host Disease and Transplant-Related Mortality
	R. A. Brown, D. Adkins, H. Khoury, R. Vij, L. T. Goodnough, S. Shenoy, and J. F. DiPersio
	JCO Mar 1 1999: 806. [Abstract] [Full Text] [PDF]

EPIDEMIOLOGY
	Age, Sex, and Smoking Are Predictors of Circulating Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor–Binding Protein 3
	Virginia G. Kaklamani, Athena Linos, Evangelia Kaklamani, Ioanna Markaki, and Christos Mantzoros
	JCO Mar 1 1999: 813. [Abstract] [Full Text] [PDF]

PEDIATRIC ONCOLOGY
	Sex Differences in Prognosis for Children With Acute Lymphoblastic Leukemia
	Ching-Hon Pui, James M. Boyett, Mary V. Relling, Patricia L. Harrison, Gaston K. Rivera, Frederick G. Behm, John T. Sandlund, Raul C. Ribeiro, Jeffrey E. Rubnitz, Amar Gajjar, and William E. Evans
	JCO Mar 1 1999: 818. [Abstract] [Full Text] [PDF]
	Autologous Hematopoietic Stem-Cell Transplantation for Relapsed or Refractory Hodgkin's Disease in Children and Adolescents
	K. Scott Baker, Bruce G. Gordon, Thomas G. Gross, Minnie A. Abromowitch, Elizabeth R. Lyden, James C. Lynch, Julie M. Vose, James O. Armitage, Peter F. Coccia, and Philip J. Bierman
	JCO Mar 1 1999: 825. [Abstract] [Full Text] [PDF]
	Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer Group 921 Randomized Phase III Study
	Paul M. Zeltzer, James M. Boyett, Jonathan L. Finlay, A. Lel Albright, Lucy B. Rorke, Jerrold M. Milstein, Jeffrey C. Allen, Kenneth R. Stevens, Philip Stanley, Hao Li, Jeffrey H. Wisoff, J. Russell Geyer, Patsy McGuire-Cullen, James A. Stehbens, Susan B. Shurin, and Roger J. Packer
	JCO Mar 1 1999: 832. [Abstract] [Full Text] [PDF]

BREAST CANCER
	Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial
	Richard L. Theriault, Allan Lipton, Gabriel N. Hortobagyi, Richard Leff, Stefan Glück, John F. Stewart, Sean Costello, Ian Kennedy, Joseph Simeone, John J. Seaman, Robert D. Knight, Kathleen Mellars, Maika Heffernan, and Dirk J. Reitsma
	JCO Mar 1 1999: 846. [Abstract] [Full Text] [PDF]
	Management of Breast Cancer During Pregnancy Using a Standardized Protocol
	David L. Berry, Richard L. Theriault, Frankie A. Holmes, Valerie M. Parisi, Daniel J. Booser, S. Eva Singletary, Aman U. Buzdar, and Gabriel N. Hortobagyi
	JCO Mar 1 1999: 855. [Abstract] [Full Text] [PDF]
	Dose-Escalation Study of Docetaxel in Combination With Mitoxantrone as First-Line Treatment in Patients With Metastatic Breast Cancer
	Charalambos Kouroussis, Nikos Androulakis, Stelios Kakolyris, John Souglakos, Thanos Kotsakis, Dimitris Mavroudis, Kostas Katsogridakis, Nikos Vardakis, Dora Hatzidaki, George Samonis, John Vlachonikolis, and Vassilis Georgoulias
	JCO Mar 1 1999: 862. [Abstract] [Full Text] [PDF]
	Quantitative Polymerase Chain Reaction for the Detection of Micrometastases in Patients With Breast Cancer
	Martin J. Slade, Brendan M. Smith, H. Dudley Sinnett, Nicholas C.P. Cross, and R. Charles Coombes
	JCO Mar 1 1999: 870. [Abstract] [Full Text] [PDF]
	Phase I Trial of Escalating Doses of Paclitaxel Plus Doxorubicin and Dexrazoxane in Patients With Advanced Breast Cancer
	Joseph A. Sparano, James Speyer, William J. Gradishar, Leonard Liebes, Rajeshwari Sridhara, Sandra Mendoza, David Fry, and Merrill J. Egorin
	JCO Mar 1 1999: 880. [Abstract] [Full Text] [PDF]
	Impact of Consolidation Radiotherapy in Patients With Advanced Breast Cancer Treated With High-Dose Chemotherapy and Autologous Bone Marrow Rescue
	Dennis L. Carter, Lawrence B. Marks, Joseph M. Bean, Gloria Broadwater, Atif Hussein, James J. Vredenburgh, William P. Peters, and Leonard R. Prosnitz
	JCO Mar 1 1999: 887. [Abstract] [Full Text] [PDF]

GASTROINTESTINAL CANCER
	Additional Value of Whole-Body Positron Emission Tomography With Fluorine-18-2-Fluoro-2-deoxy-D-glucose in Recurrent Colorectal Cancer
	Patrick Flamen, Sigrid Stroobants, Eric Van Cutsem, Patrick Dupont, Guy Bormans, Nancy De Vadder, Freddy Penninckx, Lieven Van Hoe, and Luc Mortelmans
	JCO Mar 1 1999: 894. [Abstract] [Full Text] [PDF]
	Combined Irinotecan and Oxaliplatin Plus Granulocyte Colony-Stimulating Factor in Patients With Advanced Fluoropyrimidine/Leucovorin-Pretreated Colorectal Cancer
	Werner Scheithauer, Gabriela V. Kornek, Markus Raderer, Julia Valencak, Georg Weinländer, Michael Hejna, Karin Haider, Werner Kwasny, and Dieter Depisch
	JCO Mar 1 1999: 902. [Abstract] [Full Text] [PDF]
	Phase I Study of a Weekly Schedule of Irinotecan, High-Dose Leucovorin, and Infusional Fluorouracil as First-Line Chemotherapy in Patients With Advanced Colorectal Cancer
	Udo Vanhoefer, Andreas Harstrick, Claus-Henning Köhne, Wolf Achterrath, Youcef M. Rustum, Siegfried Seeber, and Hansjochen Wilke
	JCO Mar 1 1999: 907. [Abstract] [Full Text] [PDF]

LUNG CANCER
	Front-Line Treatment of Advanced Non–Small-Cell Lung Cancer With Docetaxel and Gemcitabine: A Multicenter Phase II Trial
	Vassilis Georgoulias, Charalambos Kouroussis, Nikos Androulakis, Stelios Kakolyris, Meletios-Athanasios Dimopoulos, Emmanuel Papadakis, Dimosthenis Bouros, Fotini Apostolopoulou, Christos Papadimitriou, Athina Agelidou, Kostas Hatzakis, Kostas Kalbakis, Athanasios Kotsakis, Nikos Vardakis, and John Vlachonicolis
	JCO Mar 1 1999: 914. [Abstract] [Full Text] [PDF]
	Phase I-II Study of Gemcitabine and Carboplatin in Stage IIIB-IV Non–Small-Cell Lung Cancer
	Rosario Vincenzo Iaffaioli, Anna Tortoriello, Gaetano Facchini, Francesco Caponigro, Maria Gentile, Nicola Marzano, Adriano Gravina, Paolo Dimitri, Giuseppina Costagliola, Alessandro Ferraro, Giovanni Ferrante, Valeria De Marino, and Alfonso Illiano
	JCO Mar 1 1999: 921. [Abstract] [Full Text] [PDF]
	Paclitaxel and Carboplatin in the Treatment of Small-Cell Lung Cancer Patients Resistant to Cyclophosphamide, Doxorubicin, and Etoposide: A Non–Cross-Resistant Schedule
	Harry J.M. Groen, Eelco Fokkema, Bonne Biesma, Bibi Kwa, John W.G. van Putten, Pieter E. Postmus, and Egbert F. Smit
	JCO Mar 1 1999: 927. [Abstract] [Full Text] [PDF]

GENITOURINARY CANCER
	Phase II Trial of Primary Chemotherapy Followed by Reduced-Dose Radiation for CNS Germ Cell Tumors
	Jan C. Buckner, Prema P. Peethambaram, William A. Smithson, Robert V. Groover, Paula J. Schomberg, David W. Kimmel, Corey Raffel, Judith R. O'Fallon, Joseph Neglia, and Edward G. Shaw
	JCO Mar 1 1999: 933. [Abstract] [Full Text] [PDF]
	Semen Quality and Reproductive Hormones Before Orchiectomy in Men With Testicular Cancer
	Peter Meidahl Petersen, Niels E. Skakkebæk, Kirsten Vistisen, Mikael Rørth, and Aleksander Giwercman
	JCO Mar 1 1999: 941. [Abstract] [Full Text] [PDF]
	Prognostic Significance of Extent of Disease in Bone in Patients With Androgen-Independent Prostate Cancer
	P. Sabbatini, S. M. Larson, A. Kremer, Z.-F. Zhang, M. Sun, H. Yeung, M. Imbriaco, I. Horak, M. Conolly, C. Ding, P. Ouyang, W. K. Kelly, and H. I. Scher
	JCO Mar 1 1999: 948. [Abstract] [Full Text] [PDF]
	Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer
	Daniel P. Petrylak, Robert B. Macarthur, John O'Connor, Gary Shelton, Timothy Judge, Joshua Balog, Charles Pfaff, Emilia Bagiella, Daniel Heitjan, Robert Fine, Nancy Zuech, Ihor Sawczuk, Mitchell Benson, and Carl A. Olsson
	JCO Mar 1 1999: 958. [Abstract] [Full Text] [PDF]

MELANOMA
	Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b
	Steven A. Rosenberg, James C. Yang, Douglas J. Schwartzentruber, Patrick Hwu, Francesco M. Marincola, Suzanne L. Topalian, Claudia A. Seipp, Jan H. Einhorn, Donald E. White, and Seth M. Steinberg
	JCO Mar 1 1999: 968. [Abstract] [Full Text] [PDF]
	Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma Patients
	Jeffrey E. Gershenwald, William Thompson, Paul F. Mansfield, Jeffrey E. Lee, Maria I. Colome, Chi-hong Tseng, J. Jack Lee, Charles M. Balch, Douglas S. Reintgen, and Merrick I. Ross
	JCO Mar 1 1999: 976. [Abstract] [Full Text] [PDF]

BRAIN TUMORS
	Phase II Study of Phenylacetate in Patients With Recurrent Malignant Glioma: A North American Brain Tumor Consortium Report
	Susan M. Chang, John G. Kuhn, H. Ian Robins, S. Clifford Schold, Alexander M. Spence, Mitchel S. Berger, Minesh P. Mehta, Michael E. Bozik, Ian Pollack, David Schiff, Mark Gilbert, Cathy Rankin, and Michael D. Prados
	JCO Mar 1 1999: 984. [Abstract] [Full Text] [PDF]

SUPPORTIVE CARE AND QUALITY OF LIFE
	Outcome for Cancer Patients Requiring Mechanical Ventilation
	Jeffrey S. Groeger, Peter White, Jr, David M. Nierman, Jill Glassman, Weiji Shi, David Horak, and Kristen Price
	JCO Mar 1 1999: 991. [Abstract] [Full Text] [PDF]
	Automated Collection of Quality-of-Life Data: A Comparison of Paper and Computer Touch-Screen Questionnaires
	G. Velikova, E. P. Wright, A. B. Smith, A. Cull, A. Gould, D. Forman, T. Perren, M. Stead, J. Brown, and P. J. Selby
	JCO Mar 1 1999: 998. [Abstract] [Full Text] [PDF]
	Quality of Life in Head and Neck Cancer Patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35
	Kristin Bjordal, Eva Hammerlid, Marianne Ahlner-Elmqvist, Alexander de Graeff, Morten Boysen, Jan F. Evensen, Anders Biörklund, J. Rob J. de Leeuw, Peter M. Fayers, Magnus Jannert, Thomas Westin, and Stein Kaasa
	JCO Mar 1 1999: 1008. [Abstract] [Full Text] [PDF]
	Quality of Life and Performance in Advanced Head and Neck Cancer Patients on Concomitant Chemoradiotherapy: A Prospective Examination
	Marcy A. List, Amy Siston, Daniel Haraf, Phil Schumm, Merrill Kies, Kerstin Stenson, and Everett E. Vokes
	JCO Mar 1 1999: 1020. [Abstract] [Full Text] [PDF]
	Recruiting Minority Cancer Patients Into Cancer Clinical Trials: A Pilot Project Involving the Eastern Cooperative Oncology Group and the National Medical Association
	Worta McCaskill-Stevens, Harlan Pinto, Alfred C. Marcus, Robert Comis, Randall Morgan, Kathy Plomer, and Sarah Schoentgen
	JCO Mar 1 1999: 1029. [Abstract] [Full Text] [PDF]
	Attitudes, Knowledge, and Risk Perceptions of Women With Breast and/or Ovarian Cancer Considering Testing for BRCA1 and BRCA2
	Leslie G. Bluman, Barbara K. Rimer, Donald A. Berry, Nancy Borstelmann, J. Dirk Iglehart, Katherine Regan, Joellen Schildkraut, and Eric P. Winer
	JCO Mar 1 1999: 1040. [Abstract] [Full Text] [PDF]

BIOLOGY OF NEOPLASIA
	Cancer Vaccines
	Tim F. Greten and Elizabeth M. Jaffee
	JCO Mar 1 1999: 1047. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Mechanisms of Action of and Resistance to Antitubulin Agents: Microtubule Dynamics, Drug Transport, and Cell Death
	Charles Dumontet and Branimir I. Sikic
	JCO Mar 1 1999: 1061. [Abstract] [Full Text] [PDF]
	RAS and Leukemia: From Basic Mechanisms to Gene-Directed Therapy
	Darrin M. Beaupre and Razelle Kurzrock
	JCO Mar 1 1999: 1071. [Abstract] [Full Text] [PDF]

ASCO SPECIAL ARTICLES
	American Society of Clinical Oncology 1998 Update of Recommended Breast Cancer Surveillance Guidelines
	Thomas J. Smith, Nancy E. Davidson, David V. Schapira, Eva Grunfeld, Hyman B. Muss, Victor G. Vogel, III, and Mark R. Somerfield
	JCO Mar 1 1999: 1080. [Abstract] [Full Text] [PDF]

DIAGNOSIS IN ONCOLOGY

Unusual Manifestations of B-Cell Disorders

Mustafa Ozguroglu, Hilal Aki, Gokhan Demir, Fuat Demirelli, and Nil Molinas Mandel

JCO Mar 1 1999: 1083. [Full Text] [PDF]

Unusual Manifestions of B-Cell Disorders

Monika-H. Schmid-Wendtner, Christian Sander, Matthias Volkenandt, and Clemens-M. Wendtner

JCO Mar 1 1999: 1083a. [Full Text] [PDF]

CORRESPONDENCE

Low-Dose Chemotherapy With Vinblastine and Methotrexate in Childhood Desmoid Tumors

Susanne Reich, Ursula Schulte Overberg-Schmidt, Christoph Bührer, and Günter Henze

JCO Mar 1 1999: 1086. [Full Text] [PDF]

Prostate-Specific Antigen Decline After Withdrawal of Low-Dose Megestrol Acetate

Patrick A. Burch and Charles L. Loprinzi

JCO Mar 1 1999: 1086a. [Full Text] [PDF]

Detrimental Effects of Prechemotherapy Filgrastim

Stefan Serke, Dieter Huhn, Hans Eric Johnsen, Richard Herrmann, Vivianne C.G. Tjan-Heijnen, Bonne Biesma, Jan Festen, Ted A.W. Splinter, Anton Cox, D. J. Theo Wagener, and Pieter E. Postmus

JCO Mar 1 1999: 1086b. [Full Text] [PDF]

SPECIAL DEPARTMENTS

ERRATA

Correction for vol. 17, p. 399

JCO Mar 1 1999: 1091. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.